-mHealth Intelligence
“Telehealth advocates are once again asking the Justice Department to follow through with its pledge to create a special registration process for healthcare providers who want to prescribe controlled substances through a telemedicine platform.
As required by the Special Registration for Telemedicine Act of 2018, which was part of the SUPPORT for Patients and Communities Act signed into law by President Trump in late 2018, the US Drug Enforcement Agency has until October 24 to set the ground rules for providers with a special registration to prescribe controlled substances.
With that deadline fast approaching, the Center for Telehealth & e-Health Law (CTeL) sent a letter to Scott Brinks, section chief of the DEA’s Regulatory Drafting & Policy Support Section, urging the agency to create that special registration, which would enable provider to prescribe controlled substances without the need for a prior in-person exam.”
Click here to read the entire article.
